Olopatadine 0.2% for the Treatment of Allergic Conjunctivitis
NCT00331500
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
287
Enrollment
INDUSTRY
Sponsor class
Conditions
Allergic Conjunctivitis
Interventions
DRUG:
Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
DRUG:
Olopatadine Hydrochloride Ophthalmic Solution Vehicle
Sponsor
Alcon Research